Monday, September 8, 2025

Latest

BMO: Nuvei Expected To Record Net Revenues Of $97 Million In Q3 2020

This morning, BMO Capital Markets released a note to investors updating their forecast and model ahead of Nuvei Corporation’s (TSX: NVEI) third quarter earnings, which are expected to be released on November 11th before market open. This is also Nuvei’s first release of result as a public company. BMO has a C$46 price target and a market perform rating on the company.

BMO notes that they are slightly changing their third-quarter and full-year 2020 core earnings per share (EPS) and Adjusted EBITDA estimates, while maintaining their 2021 and 2022 core EPS estimates at $0.87 and $1.02, respectively.

They now expect core EPS to be $0.08, down 1 penny from previous estimates, while adjusted EBITDA is now forecasted to come in at $42 million versus the prior estimate of $44 million. This slight change is due to their, “updated 3Q20E reported EPS of -$0.58 include nonrecurring finance charges of $80 million related to NVEI’s recent IPO.”

The main reason for the slight adjustments is due to them incorporating non-recurring charges due to the IPO into their EPS calculations.

James Fotheringham, BMO’s analyst, highlights a “positive read-across from peers,” as Visa, Mastercard and Paypal all had better than expected volume growth. Roughly 70% of Nuvei’s revenues are from online transactions, resulting in marginal impact from current pandemic conditions.

For the third quarter, BMO expects $97 million in net revenues, along with a gross profit of $81 million, based on total payment volumes of $10.5 billion. Core operating expenses are estimated to be $73 million, along with non-recurring finance charges amounting to $80 million in connection with the recent IPO. In terms of the current price target, BMO ascribes the company a 44.7x two-year-forward price to earnings multiple.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Ascend Wellness: Canaccord Lowers Target To US$10

On January 14th, after a number of press releases from Ascend Wellness Holdings, Inc. (CSE:...

Friday, January 21, 2022, 04:20:00 PM

Curaleaf: Haywood Reiterates $22 Price Target, Names Firm A Top Pick For 2022

On December 28th, Curaleaf Holdings (CSE: CURA) announced that they have entered into a definitive agreement...

Friday, December 31, 2021, 04:35:00 PM

Salesforce: BMO Lifts Target To $335

On September 23, Salesforce.com (NYSE: CRM) announced that they are raising their fiscal full-year 2022...

Friday, October 1, 2021, 02:39:00 PM

Canopy Growth Sees Canaccord Lower Target To $10 After Poor Q3 Results

On February 7th, Canopy Growth Corp (TSX: WEED) reported its fiscal third quarter financial results....

Sunday, February 13, 2022, 01:03:00 PM

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM